| Primary |
| Pain |
28.1% |
| Product Used For Unknown Indication |
14.8% |
| Back Pain |
12.4% |
| Drug Use For Unknown Indication |
5.9% |
| Breakthrough Pain |
4.8% |
| Cancer Pain |
4.7% |
| Hypertension |
3.4% |
| Depression |
3.2% |
| Fibromyalgia |
3.0% |
| Anxiety |
2.6% |
| Arthralgia |
2.2% |
| Arthritis |
1.9% |
| Blood Pressure |
1.9% |
| Diabetes Mellitus |
1.8% |
| Neuropathy Peripheral |
1.8% |
| Pain In Extremity |
1.7% |
| Sleep Disorder |
1.6% |
| Neck Pain |
1.5% |
| Neuralgia |
1.5% |
| Insomnia |
1.4% |
|
| Wrong Technique In Drug Usage Process |
26.7% |
| Drug Prescribing Error |
11.6% |
| Product Quality Issue |
7.8% |
| Drug Ineffective |
5.9% |
| Toxicity To Various Agents |
5.4% |
| Overdose |
4.6% |
| Inappropriate Schedule Of Drug Administration |
4.3% |
| Pain |
3.9% |
| Drug Withdrawal Syndrome |
3.7% |
| Withdrawal Syndrome |
3.0% |
| Drug Effect Decreased |
3.0% |
| Product Adhesion Issue |
2.9% |
| Death |
2.8% |
| Somnolence |
2.3% |
| Drug Toxicity |
2.2% |
| Drug Administered At Inappropriate Site |
2.2% |
| Delirium |
2.1% |
| Nausea |
2.1% |
| Vomiting |
2.0% |
| Inadequate Analgesia |
1.5% |
|
| Secondary |
| Pain |
23.2% |
| Back Pain |
14.3% |
| Product Used For Unknown Indication |
8.2% |
| Fibromyalgia |
6.4% |
| Breakthrough Pain |
4.8% |
| Arthralgia |
4.3% |
| Cancer Pain |
3.8% |
| Pain In Extremity |
3.6% |
| Depression |
3.3% |
| Hypertension |
3.2% |
| Drug Use For Unknown Indication |
2.8% |
| Arthritis |
2.8% |
| Neuropathy Peripheral |
2.6% |
| Neck Pain |
2.6% |
| Rheumatoid Arthritis |
2.6% |
| Prophylaxis |
2.5% |
| Anxiety |
2.5% |
| Blood Pressure |
2.3% |
| Muscle Spasms |
2.2% |
| Migraine |
2.1% |
|
| Wrong Technique In Drug Usage Process |
26.9% |
| Product Quality Issue |
9.5% |
| Drug Ineffective |
8.7% |
| Pain |
7.1% |
| Withdrawal Syndrome |
5.0% |
| Somnolence |
4.5% |
| Drug Administered At Inappropriate Site |
3.9% |
| Drug Withdrawal Syndrome |
3.6% |
| Product Adhesion Issue |
3.6% |
| Therapeutic Response Decreased |
3.4% |
| Inappropriate Schedule Of Drug Administration |
3.4% |
| Nausea |
3.4% |
| Toxicity To Various Agents |
2.7% |
| Drug Dose Omission |
2.7% |
| Vomiting |
2.1% |
| Drug Effect Decreased |
2.0% |
| Drug Prescribing Error |
2.0% |
| Headache |
1.9% |
| Treatment Noncompliance |
1.9% |
| Weight Decreased |
1.8% |
|
| Concomitant |
| Drug Use For Unknown Indication |
31.0% |
| Product Used For Unknown Indication |
18.7% |
| Pain |
10.2% |
| Prophylaxis |
6.6% |
| Multiple Myeloma |
5.2% |
| Hypertension |
3.2% |
| Nausea |
2.8% |
| Constipation |
2.7% |
| Diffuse Large B-cell Lymphoma |
2.3% |
| Back Pain |
2.0% |
| Depression |
1.9% |
| Non-small Cell Lung Cancer |
1.8% |
| Cancer Pain |
1.6% |
| Induction Of Anaesthesia |
1.5% |
| Anaesthesia |
1.5% |
| Multiple Sclerosis |
1.4% |
| Anxiety |
1.4% |
| Rheumatoid Arthritis |
1.4% |
| Crohn's Disease |
1.3% |
| Head And Neck Cancer |
1.3% |
|
| Vomiting |
13.1% |
| Pain |
11.1% |
| Death |
6.0% |
| Weight Decreased |
6.0% |
| Urinary Tract Infection |
5.5% |
| Respiratory Failure |
5.1% |
| Pneumonia |
4.9% |
| Thrombocytopenia |
4.9% |
| White Blood Cell Count Decreased |
4.4% |
| Nausea |
4.3% |
| Pulmonary Embolism |
4.3% |
| Pyrexia |
4.3% |
| Drug Ineffective |
3.8% |
| Renal Failure |
3.6% |
| Unevaluable Event |
3.6% |
| Injury |
3.4% |
| Tachycardia |
3.2% |
| Weight Increased |
3.2% |
| Tremor |
2.7% |
| Platelet Count Decreased |
2.6% |
|
| Interacting |
| Pain |
15.8% |
| General Anaesthesia |
15.1% |
| Product Used For Unknown Indication |
14.3% |
| Musculoskeletal Pain |
8.1% |
| Osteotomy |
8.1% |
| Drug Use For Unknown Indication |
5.0% |
| Chronic Obstructive Pulmonary Disease |
4.6% |
| Maintenance Of Anaesthesia |
3.9% |
| Anaesthesia |
3.5% |
| Varicose Vein Operation |
3.1% |
| Neuralgia |
2.7% |
| Procedural Pain |
2.7% |
| Induction Of Anaesthesia |
2.3% |
| Cancer Pain |
1.9% |
| Analgesia |
1.5% |
| Helicobacter Infection |
1.5% |
| Hiv Infection |
1.5% |
| Hypertension |
1.5% |
| Pain In Extremity |
1.5% |
| Back Pain |
1.2% |
|
| Myoclonus |
14.9% |
| Drug Interaction |
12.8% |
| Somnolence |
10.6% |
| Hypoventilation |
8.5% |
| Sinus Tachycardia |
8.5% |
| Myotonia |
6.4% |
| Dyspnoea |
4.3% |
| Respiratory Arrest |
4.3% |
| Respiratory Depression |
4.3% |
| Tremor |
4.3% |
| Abnormal Dreams |
2.1% |
| Cardiac Arrest |
2.1% |
| Confusional State |
2.1% |
| Drug Toxicity |
2.1% |
| Extensor Plantar Response |
2.1% |
| No Adverse Event |
2.1% |
| Pain |
2.1% |
| Respiratory Failure |
2.1% |
| Serotonin Syndrome |
2.1% |
| Tracheal Haemorrhage |
2.1% |
|
